137 related articles for article (PubMed ID: 6222094)
1. Maprotiline in affective illness. Plasma concentration and clinical response.
Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
[TBL] [Abstract][Full Text] [Related]
2. Maprotiline versus imipramine and placebo in neurotic depression.
van der Velde CD
J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
[TBL] [Abstract][Full Text] [Related]
3. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
Gaertner HJ; Golfinopoulos G; Breyer-Pfaff U
Pharmacopsychiatria; 1982 Sep; 15(5):170-4. PubMed ID: 7178231
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
[TBL] [Abstract][Full Text] [Related]
5. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
[TBL] [Abstract][Full Text] [Related]
6. [The effect of maprotiline on target symptoms of depressive states].
Faltus F
Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
[No Abstract] [Full Text] [Related]
7. Clinical experience with maprotiline.
Kabes J; Dostal T; Roth Z
Act Nerv Super (Praha); 1982 May; 24(2):93-8. PubMed ID: 7048837
[No Abstract] [Full Text] [Related]
8. Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
Levin A
Int Pharmacopsychiatry; 1982; 17 Suppl 1():89-96. PubMed ID: 6752081
[TBL] [Abstract][Full Text] [Related]
9. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
Møller SE; de Beurs P; Timmerman L; Tan BK; Leijnse-Ybema HJ; Stuart MH; Petersen HE
Psychopharmacology (Berl); 1986; 88(1):96-100. PubMed ID: 3080781
[TBL] [Abstract][Full Text] [Related]
10. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
Fabre LF
J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
[TBL] [Abstract][Full Text] [Related]
11. [Further clinical experiences with maprotiline in endogeneous depressions].
Náhunek K; Svestka J; Rysánek R; Cesková E
Act Nerv Super (Praha); 1982 May; 24(2):81-7. PubMed ID: 7048835
[No Abstract] [Full Text] [Related]
12. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
Pecknold JC; Familamiri P; McClure DJ; Elie R; Chang H
J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
[TBL] [Abstract][Full Text] [Related]
13. [Maprotiline in psychiatric ambulatory care].
Vinar O
Act Nerv Super (Praha); 1982 May; 24(2):112-8. PubMed ID: 7102223
[No Abstract] [Full Text] [Related]
14. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Classen W
Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
[TBL] [Abstract][Full Text] [Related]
15. EEG characteristics of clinically defined on-drug-responders and non-responders--a comparison clomipramine vs. maprotiline.
Ulrich G; Haug HJ; Stieglitz RD; Fähndrich E
Pharmacopsychiatry; 1988 Nov; 21(6):367-8. PubMed ID: 3244769
[No Abstract] [Full Text] [Related]
16. The antidepressant efficacy of zimelidine and maprotiline.
Montgomery SA; Rani SJ; McAuley R; Roy D; Montgomery DB
Acta Psychiatr Scand Suppl; 1981; 290():219-24. PubMed ID: 6452792
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of maprotiline and zimelidine and their relationship to clinical response in depressed patients.
Hrdina PD; Lapierre YD
Ther Drug Monit; 1986; 8(4):400-6. PubMed ID: 2950616
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
[TBL] [Abstract][Full Text] [Related]
19. Relationship between blood concentrations and clinical effects of a new antidepressant "maprotiline".
Watanabe S; Yokoyama S; Kubo S; Iwai H; Kuyama C
Folia Psychiatr Neurol Jpn; 1980; 34(2):147-56. PubMed ID: 7007180
[TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report.
Edwards JG; Goldie A
Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):239S-248S. PubMed ID: 6337611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
